BioLife Solutions, Inc. Share Price Today: Live Updates & Key Insights

BioLife Solutions, Inc. share price today is $18.87, up -3.48%. The stock opened at $19.13 against the previous close of $19.53, with an intraday high of $19.265 and low of $18.82.

BioLife Solutions, Inc. Share Price Chart

BioLife Solutions, Inc.

us-stock
To Invest in {{usstockname}}
us-stock

BioLife Solutions, Inc. Share Price Performance

$18.87 -0.0348(-3.48%) BLFS at 23 Mar 2026 12:15 PM Medical Instruments & Supplies
Lowest Today 18.82
Highest Today 19.265
Today’s Open 19.13
Prev. Close 19.53
52 Week High 29.62
52 Week Low 17.86
Day’s Range: Low 18.82 High 19.265
52-Week Range: Low 17.86 High 29.62
1 day return -
1 Week return -1.2
1 month return -17.45
3 month return -25.88
6 month return -25.26
1 year return -28.65
3 year return -10.61
5 year return -50.94
10 year return -

BioLife Solutions, Inc. Institutional Holdings

Casdin Capital, LLC 12.33

BlackRock Inc 11.60

T. Rowe Price Investment Management,Inc. 8.42

Amvescap Plc. 7.45

Vanguard Group Inc 6.39

iShares Core S&P Small-Cap ETF 4.91

T. Rowe Price US Small-Cap Core Equity 4.52

T. Rowe Price Small-Cap Stock 4.51

FMR Inc 3.21

State Street Corp 3.02

Vanguard Total Stock Mkt Idx Inv 2.97

T. Rowe Price Instl Small-Cap Stock 2.43

Fred Alger Management, LLC 2.24

Dimensional Fund Advisors, Inc. 2.12

Alger Small Cap Focus Composite 2.12

Alger Small Cap Focus I 2.12

Massachusetts Financial Services Company 2.08

T. Rowe Price U.S. SC Core Eq Tr-D 2.08

iShares Russell 2000 ETF 2.06

Geode Capital Management, LLC 1.97

Royal Bank of Canada 1.90

Ameriprise Financial Inc 1.88

Invesco Main Street Small Cap R6 1.86

Invesco Small Cap Core 1.86

Palisade Capital Management LLc 1.68

Geneva Capital Management 1.66

Rockefeller Capital Management L.P. 1.46

MFS New Discovery I 1.46

Columbia Acorn Inst 1.44

Stephens Inv Mgmt Group LLC 1.26

Stephens Small Cap Growth 1.26

Fidelity Small Cap Growth 1.21

Morgan Stanley - Brokerage Accounts 1.20

Mutual Of America Capital Management LLC 1.19

JNL/Invesco Small Cap Growth A 1.15

Gagnon Securities LLC 1.11

Palisade Small Cap Core Equity 1.01

Invesco Small Cap Growth A 0.98

Invesco V.I. Main Street Small Cap I 0.95

Vanguard Institutional Extnd Mkt Idx Tr 0.87

BioLife Solutions, Inc. Market Status

Strong Buy: 7

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

BioLife Solutions, Inc. Fundamentals

Market Cap 910.46 M

PB Ratio 2.4482

PE Ratio 0.0

Enterprise Value 839.43 M

Total Assets 405.88 M

Volume 602662

BioLife Solutions, Inc. Company Financials

Annual Revenue FY23:154797000 154.8M, FY22:161759000 161.8M, FY21:119156000 119.2M, FY20:48087000 48.1M, FY19:27371000 27.4M

Annual Profit FY23:51473000 51.5M, FY22:53822000 53.8M, FY21:37748000 37.7M, FY20:27441000 27.4M, FY19:18513000 18.5M

Annual Net worth FY23:-102234000 -102.2M, FY22:-139805000 -139.8M, FY21:-8383000 -8.4M, FY20:2667000 2.7M, FY19:11062000 11.1M

Quarterly Revenue Q3/2025:28067000 28.1M, Q2/2025:25421000 25.4M, Q1/2025:23941000 23.9M, Q3/2024:30571000 30.6M, Q2/2024:28328000 28.3M

Quarterly Profit Q3/2025:17222000 17.2M, Q2/2025:16433000 16.4M, Q1/2025:15786000 15.8M, Q3/2024:21806000 21.8M, Q2/2024:14893000 14.9M

Quarterly Net worth Q3/2025:621000 0.6M, Q2/2025:-15838000 -15.8M, Q1/2025:-448000 -0.4M, Q3/2024:-1703000 -1.7M, Q2/2024:-20719000 -20.7M

About BioLife Solutions, Inc. & investment objective

Company Information BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction products, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; CryoCase cryo-compatible transparent rigid containers for closed-system fill and retrieval, and automated cell processing machines; and the ThawSTAR line include automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

Organisation Medical Instruments & Supplies

Employees 155

Industry Medical Instruments & Supplies

CEO Mr. Roderick de Greef

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

BioLife Solutions, Inc. FAQs

What is the share price of BioLife Solutions, Inc. today?

The current share price of BioLife Solutions, Inc. is $18.87.

Can I buy BioLife Solutions, Inc. shares in India?

Yes, Indian investors can buy BioLife Solutions, Inc. shares by opening an international trading and demat account with Motilal Oswal.

How to buy BioLife Solutions, Inc. shares in India?

You can easily invest in BioLife Solutions, Inc. shares from India by:

Can I buy fractional shares of BioLife Solutions, Inc.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of BioLife Solutions, Inc.?

BioLife Solutions, Inc. has a market cap of $910.46 M.

In which sector does BioLife Solutions, Inc. belong?

BioLife Solutions, Inc. operates in the Medical Instruments & Supplies sector.

What documents are required to invest in BioLife Solutions, Inc. stocks?

To invest, you typically need:

What is the PE and PB ratio of BioLife Solutions, Inc.?

The PE ratio of BioLife Solutions, Inc. is N/A and the PB ratio is 2.45.